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Summary
Inactivated or subunit virus preparations have been excellent vaccines for inducing antibody
responses. Generation of cytolytic T cell responses, however, is thought to require replicating
virus, primarily to provide sufficiently large amounts of cytoplasmic proteins for processing and
presentation on major histocompatibility complex class I molecules by antigen-presenting cells.
Potent human CD8+ cytolytic T cell responses to live replicating influenza A virus are gener-
ated when dendritic cells are used as the antigen-presenting cells. Here, we demonstrate that
dendritic cells pulsed with poorly replicating, heat- or ultraviolet-inactivated influenza virus,
induce equally strong CD8+ cytolytic T lymphocyte responses. The cytotoxic T lymphocytes
are generated in the apparent absence ofCD4+ helper cells or exogenous cytokines. Active vi-
ral protein synthesis is not required to charge class I molecules on dendritic cells. When pulsed
with inactivated virus, G1% of dendritic cells express nonstructural protein 1, which is only
synthesized in the infectious cycle. To be optimally effective, however, the inactivated virus
must retain its fusogenic activity, and presumably access the cytoplasm of dendritic cells . The
data indicate, therefore, that dendritic cells require only small amounts of viral protein to
charge class I molecules, most likely via traditional class I processing pathways. These results re-
open the potential use of inactivated virus preparations as immunogens for cytotoxic T lym-
phocyte responses.
CD8+ CTLs are considered to be important mediators
of resistance against malignancies (1) and infections
(2-7). CTLs recognize antigens that are synthesized within
the cytoplasm ofan APC, e.g., during viral infection (8) or
that access the cytoplasm by other means, e.g., via lipo-
somes (9, 10). After specific proteolytic steps, peptides from
antigenic proteins are conveyed to the rough endoplasmic
reticulum under the influence of the TAP gene products,
where they bind to newly synthesized MHC class I mole-
cules (11). The MHC class I-peptide complexes are then
transported to the cell surface where only small amounts
(-200) are sufficient to be recognized by antigen-specific
CTLs (12). There is evidence to suggest that the processing
of proteins to form MHC class I-peptide complexes is
quantitatively inefficient. Target cells infected with UV-
inactivated influenza virus, which accesses the cytoplasm
but does not replicate, are not lysed by active CTLs (8, 13-
15). Instead, active viral protein synthesis seems necessary
for the requisite small number of MHC-peptide complexes
to form. These findings apply to fully formed or effector
CTLs, but a similar inefficiency seems to apply during the
A preliminary report of this work was presented in abstract form at the
Keystone Symposium on Dendritic Cells in Taos, NM), 11-15 March
1995.
generation of CTLs from quiescent CD8+ precursors. Re-
peated stimulation with antigen and exogenous addition of
IL-2 are often required to produce effector CTLs (3, 16-
18) . As a result, inactivated or nonreplicating virus vaccines
have not been used to generate CTL-mediated immunity.
The immune system, however, does have a specialized
pathway to elicit CTLs with great efficiency. When anti-
gen is presented on dendritic cells, CTLs recognizing trans-
plantation antigens, tumor antigens, H-Y, and viral anti-
gens, are proficiently generated (for review, see reference
19) . In all instances, dendritic cells are more potent in elic-
iting the CTL responses than other APCs. In a recent ex-
ample, we have demonstrated that human dendritic cells
elicit vigorous CTL responses to influenza A virus from
primed donors (20). The responses can be elicited with a
few dendritic cells (APC/T cell ratio of 1 :50-1 :200), and
develop in the absence of CD4' helper T cells. Whereas
both dendritic cells and monocytes can be infected with in-
fluenza virus, only the former serve as effective APCs for
CTL induction. The latter can act as targets for the CTLs
once induced. This proficiency to induce CTLs on the part
of dendritic cells has been ascribed to several features. In-
fluenza virus infects most dendritic cells from human blood.
The infection appears to be nonproductive and nontoxic
since the cells are not lysed, and the cells remain viable for
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class I molecules forlong periods. Nevertheless, the efficacy
with which dendritic cells process proteins onto MHC class
I molecules is unclear, i.e., how much native antigen must
be taken up by dendritic cells for their specialized present-
ing activities to become manifest? Here we report that den-
dritic cells successfully present nonreplicating influenza
virus to CD8+ T cells. For optimal CTL induction, the
nonreplicating virus needs to access the cytoplasm, imply-
ing that dendritic cells efficiently process proteins for pre-
sentation on MHC class I molecules. These results reopen
the possible use of nonreplicating or inactivated virus as an
immunogen for generating CTLs, as long as the antigen is
presented by dendritic cells.
Materials and Methods
Culture Medium
RPMI 1640 (Gibco Laboratories, Grand Island, NY) supple-
mented with 20 Kg/ml gentamicin, 5% human serum, and 10
mM Hepes buffer was used.
Blood Mononuclear Cells
PBMCs were obtained from buffy coats by density gradient
centrifugation over Ficoll Hypaque and separated into T cell-
enriched and Tcell-depleted (ER-)' fractions by sheep erythro-
cyte rosetting. T cells were purified by removal of monocytes,
NK cells, and MHC class II+ cells as previously described (20) . T
cell subsets (CD4+ and CD8+) were prepared by incubation with
Leu 2 or Len 3 niAbs, followed by panning onto plastic plates
coated with goat anti-mouse IgG. Alternatively, T cells were
sorted into CD4+ andCD8+ subsets on a FACSorter® afterstain-
ingwith SimultestCD4-FITC/CD8-PE-conjugated mAbs (Bec-
ton Dickinson and Co., Mountain View, CA). Monocytes were
obtained from ER- cells by plastic adherence. Nonadherent
ER- cells were depleted of residual monocytes by panning on
,y-globulin-coated dishes. The remaining cells (primarily B cells
and dendritic cells) were adequately enriched for dendritic cells to
induce strong CTL responses. B cells are not infected with influ-
enza Avirusand therefore do not elicit CTLresponses (20) . Highly
purified dendritic cells were obtained as low density cells by me-
trizamide gradient centrifugation, as previously described (20) .
Virus Preparation
Influenza A virus (PR8, Puerto Rico/8/34, source: allantoic
fluid; Spafas Inc., Storrs, CT) was either live, inactivated at 56°C
for 30 min in a water bath, or exposed on ice to shortwave UV
radiation at 254 nm (Mineralight UV lamp, UVGL58; Ultra-Vio-
let Products, San Gabriel, CA) for 40 min at a distance of 4 cm.
Influenza virus purified on sucrose density gradients (Spafas Inc.)
was also used in some experiments.
Assaysfor Viral infectivity, Titer, and Fusogenic Capacity
infectivity.
￿
Amodified plaque assay wasperformed using tryp-
sin-resistant Madin-Darby canine kidney-II cells (21) . Cells were
'Abbreviations used in this paper: ER-, T cell depleted; HA, hemaggluti-
nin; HAU, hemagglutinating units; MOI, multiplicity of infection; NA,
neuraminidase; NP, nucleoprotein; NS-1, nonstructural protein 1.
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grown in six-well plates to monolayerdensity, washed once with
RPMI 1640, and then inoculated with 0.33 ml ofserially diluted
virus preparations. After a 1-h incubation at 37°C, the cells were
washed, and overlaid with 0.6% agarose solution (type L; Behr-
ingwerke, Marburg, Germany) in RPMI 1640 with freshly added
trypsin (2.5-5.0 l ,g/ml) . After 3 d, cultures were stained with
0.2% crystalviolet solution containing 4% formaldehyde. Plaques
were visualized and enumerated as plaque-forming units calcu-
lated per milliliter. An EID5o assay was done by injecting serially
diluted virus into embryonated hen eggs. The EID5,/ml for live
virus was >I04greater than forheat-treated virus.
Titer.
￿
A standard hemagglutination assay with chicken RBC
(CRBC) was used for quantitation of virus in hemagglutinating
units (HAU) per milliliter (22).
Fusogenic capacity.
￿
Viral fusion activity was determined using
an assay that relies on the hemolysisofCRBC by virus at low pH
(23, 24). CRBC were preincubated with virus at room tempera-
ture for 15 min to permit binding. pH was then adjusted to 5 and
the virus-CRBC preparations were incubated at 37°C for 30 min
to induce fusion and subsequently hemolysis. The amount ofhe-
moglobin released was determined by absorption at 410 nm. Fu-
sogenic capacity was eliminated by exposure of virus to citrate
buffer at pH 5 for30 min. This did not significantly alter binding
(hemagglutinating) capacity, but resulted in loss of fusogenic ac-
tivity and a substantial decrease in infectivity (>4 X 104-fold).
Viral Adsorption.
￿
Influenza virusin allantoic fluidwas adsorbed
to CRBC to remove intact virions. CRBC were resuspended to
20% vol/vol in RPMI 1640 and mixed with an equal volume of
allantoic fluid. After 20 min ofincubation on ice, cells and bound
virus were spun down at "low speed" (1,000 rpm, 5 min, 4°C) .
Supernatants were adsorbed two more times with CRBC as
above. The final supernatant was considered to be a 1:8 dilution
ofthestarting preparation.
Induction of CTL Responses
Dendritic cells were infected with 1,000 HAU/ml (multiplic-
ity of infection [MOI] of 2-4 for live virus) of different forms of
virus for 1 h at 37°C in serum-free medium, washed extensively,
and added to bulk cultures of purified syngeneic T cells in 24-
well plastic dishes. After 7 d, influenza-specific effector cells were
harvested anddistributed in varyingnumbers in 100-li.l vol to 96-
well microtiter plates. CTL activity in cell cultures was measured
using a standard "Cr-release assay with infected or uninfected
macrophages, as previously described (20). In brief, macrophages
were brought up to 107/ml in serum-free medium, and infected
with 1,000 HAU/ml ofinfluenza virus. They were simultaneously
labeled with 5'Cr by the addition of 400 P,Ci of Na5'CrO4 (1
mCi/ml, sterile stock; New England Nuclear, Boston, MA) per
ml. Targets were then washed four times, resuspended to 2 X
105/ml, and aliquoted in 50-p,l vol to 96-well round-bottomed
dishes containing effector cells. Percent specific 5'Cr release was
calculated from the following formula: 100 X ([release by CTL -
spontaneous release]/[total release - spontaneous release]). Spon-
taneous release was generally 15% ofthe total release.
FACS1Analysis of Cell Populations
Cells were fixed with 4% paraformaldehyde, washed, and per-
meabilized with 1% saponin for 30 min at 4°C (25) . Anti-NSl
(kindly provided by Dr. J. Yewdell, National Institutes ofHealth,
Bethesda, MD) or isotype control (anti-CD8) nrAbs were added
for 30 min. Cells were washed in a solution of PBS containing
0.1% saponin, 0.1% azide, and 1% FCS and human serum, incu-
Inactivated Virus Induces Human CD8+ Cytolytic T Cell Responsesbated with 1 :200 dilution ofPE-conjugated goat anti-mouse IgG
(Boehringer Mannheim Biochemicals, Indianapolis, IN), washed,
and analyzed on a FACScan® (Becton Dickinson andCo .) .
Detection of Viral Proteins by Immunohistochemistry
Cytospins of dendritic cell populations were fixed in acetone
for 5 min, and incubated for 45 min with anti-NS1 or anti-NP
mAbs (H16-L10-4R5 ; American Type Culture Collection HB65,
provided by Dr . J . Yewdell) as described (20) . After washing,
slides were incubated with biotinylated goat anti-mouse Ig for 45
min, followed by a horseradish peroxidase biotin-avidin complex
for 30 min . The HRP reaction product was developed with
HZO2 and diaminobenzidine tetrahydrochloride .
Results
Live and Inactivated Influenza VirusesAre Presented by Den-
dritic Cells to CTL Precursors . Different forms of influenza
A virus (PR8) were used to generate secondary virus-spe-
cific CTL responses from several blood donors . As shown
previously (20), when dendritic cells were pulsed with rep-
licating ("live") virus (MOI of 2-4), CTLs were generated
that recognize virus-infected but not uninfected targets
(Table 1, top row) . Remarkably, when dendritic cells were
pulsed with equivalent intact virion doses ofnonreplicating
influenza virus, comparable CTL responses were induced.
Influenza virus could be inactivated either by heating for30
min at 56°C, or by exposure to IN light (Table 1, rows 2
and 3) . These procedures reduced virus infectivity by >104-
fold (Table 1, middle column) . Heat inactivation, in partic-
ular, reliably reduced viral inactivity >106-fold . Through
its envelope hemagglutinin, influenza virus binds to sialic
acid residues on cell surfaces, permitting adsorptive endo-
cytosis of virus into cells . In acidic endosomes, the hemag-
glutinin undergoes a pH-dependent conformational change
that leads to fusion and delivery of viral nucleocapsid into
the cytoplasm (26, 27). The binding and fusogenic func-
tions ofinactivated influenza virus were intact as assessed by
standard hemagglutinating (binding) and hemolytic (fusion)
assays, and confirmed earlier studies (13, 28) . The impor-
tance of an intact hemagglutinin was further demonstrated
by exposing virus to 60°C for 30 min (which partly dena-
Table 1 .
￿
Poorly Infectious Forms ofInfluenza Virus Induce Human CTLResponses
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Figure 1 .
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Ability ofheat-inactivated virus to generate CTL responses is
dependent on temperature ofinactivation. Live (replicating), heat-inacti-
vated [56°C vs 60°Cl, and UV-inactivated forms of influenza virus were
compared in their ability to generate CTL responses from blood donors.
Target cells were syngeneic uninfected and live influenza virus-infected
macrophages . E/T ratio was 50 :1 . Lysis of uninfected targets was <5%
(data not shown) .
tures the hemagglutinin [29]) . This abolished the hemag-
glutinating and hemolytic properties of the virus as well as
the capacity to elicit CTL responses (Fig . 1) . Treatment at
higher temperatures (100°C) also destroyed CTL-inducing
ability (data not shown) . Therefore inactivated virus is pre-
sented to CTL precursors by dendritic cells, but the virus
must retain bindingand fusogenic activity .
The ability of dendritic cells to induce cytolytic re-
sponses to nonreplicating, heat-inactivated, and LJV-irradi-
ated virus was observed in >20 experiments . This finding
stands in striking contrast to the inefficacy ofinactivated in-
fluenza virus to charge class I molecules when it has been
applied to target cells (8, 13-15) . These earlier studies showed
that CTL-mediated lysis of influenza virus-infected target
cells required new viral protein synthesis . To investigate
the phenomenon in more detail, we performed dose-
response titrations where graded doses of inactivated virus
were pulsed onto dendritic cells, and the ability to induce
CTL responses was evaluated . Both LN- and heat-inacti-
vated viruses were comparable to replicating virus in suc-
cessfully charging dendritic cells with antigen forCTL gen-
eration (compare closed and open symbols in Fig . 2, A and
Live (replicating), heat-inactivated, and UV-inactivated forms of influenza virus were compared in their ability to generate CTL responses from
blood donors . CTL responses are representative of >20 experiments . *E/T ratio . Target cells were syngeneic uninfected and live influenza virus-
infected macrophages . Lysis ofuninfected targets was <5%. For each virus form, the average viral and hemagglutination titers are listed in terms of
plaque-forming units per milliliter and hemagglutinating units per milliliter, respectively . Hemolysis reflects the fusogenic capacity ofvirus to lyse
chicken erythrocytes (CRBC) at acidic pH (see Materials andMethods) .
Influenza virus 50 :1
CTL response
Specific Lysis*
15:1 5 :1
Viral titers
PFU/ml
Hemagglutination
HAU/ml
Hemolysis
Replicating 31 21 8 6.4 ± 2.2 X 108 1-2 X 104 +
Heat-inactivated, 56°C 44 25 9 -_3X10 2 0.5-2X104 +
UV-inactivated 42 24 9 1.3±1.3X104 0.5-2X104 +4
v
v Y 3
N N a) 2 o m c - 1
0
None
"- Live
- Heat
None
Influenza virus dose [HAU/mll
Figure 2.
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Dose-response titration of live virus inactivated virus. Par-
tially enriched preparations ofdendritic cells were pulsed with several di-
lutions of live, heat-inactivated or UV-irradiated virus, washed, and
added to syngeneic donor Tcells at a 3 :1 T:APC ratio (20). CTL activity
was assayed on infected syngeneic monocyte targets, as described in Table
1 . E/T ratios: 60 :1 (A), 50 :1 (B). Lysis of uninfected targets was <5%
(data not shown).
B). Thus, despite the substantial reduction in infectious ti-
ters of the heated and UV-treated viruses (Table 1), they
retained the ability to induce CTL responses even at low
virion doses (e.g., 10-100 HAU/ml) similar to live virus.
We considered the possibility that live virus infection might
compromise antigen presentation, as an explanation for the
overlapping dose-response curves for live vs inactivated vi-
rus. However, we have previously shown that influenza vi-
rus-infected APCs could present purified protein derivative
to Mycobacterium tuberculosis-reactive T cell clones as well as
uninfected APCs (20) .
Absence of New Viral Protein Synthesis in Dendritic Cells In-
fected with Inactivated Influenza Virus. Unlike live virus, heat-
inactivated virus was deficient in synthesizing new viral
proteins in dendritic cells (see below) and monocytes (data
not shown). This was evident by (a) cyrofluorography (in-
aCD8
￿
aNS1
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tracellular staining with an mAb to nonstructural protein 1,
or NS1, Fig. 3), and (b) by immunocytochemistry for newly
synthesized viral NS1 and nucleoprotein antigens (Fig. 4).
The advantage of using NS1 is that it is synthesized only in
the infectious cycle and is not present in mature virions.
With nonreplicating virus, synthesis of new viral antigen
was rarely detectable. Fewer than 1% of the dendritic cells
showed staining for viral antigens like NS-1, compared
with >60-80% of the dendritic cells that had been pulsed
with live virus. Our findings confirm other studies in the
murine system demonstrating the lack of new viral protein
synthesis by heat-treated or UV-irradiated virus (13, 14).
Human CTL responses to live influenza virus are generally
obtained with T :dendritic cell ratios of 30 :1-200:1 . For
heat-inactivated virus, this corresponds to a T:dendritic
cell ratio of 3,000:1-20,000:1, if one considers that only
dendritic cells in which viral protein synthesis is occurring
are capable of inducing CTL responses. At these T:den-
dritic cell ratios, however, CTL responses cannot be gener-
ated (20) . Thus it seems that active viral protein synthesis is
not required to charge class I molecules on dendritic cells.
Instead, the small amounts of protein brought into den-
dritic cells by noninfectious particles suffice to induce CTL
responses.
Free viral proteins or peptides in allantoic fluid did not
account for the immunogenicity of the live or inactivated
virus preparations. Adsorption of intact virions with CRBC
removed all sensitizing activity from the allantoic fluid for
dendritic cells and monocytes at the induction (Fig. 5, top)
and target level, respectively (Fig. 5, bottom) . The CRBC-
adsorbed fractions demonstrated virus activity in a tissue
culture infectious dose (TCID)SO assay (data not shown) .
Therefore antigens presented within inactivated virus prepa-
rations are only associated with virus that can bind to
CRBC, rather than free proteins or peptides.
CD4+ and CD8+ T Cells Respond to Inactivated Virus-
pulsed Dendritic Cells. We next verified that the CTLs that
had been induced by dendritic cells pulsed with inactivated
virus were CD8+ T lymphocytes. T cells were purified
into respective CD8+ and CD4+ subsets, either after or be-
fore culture with virus-pulsed dendritic cells. When the T
cells were sorted after killer activity had been induced by
dendritic cells, all the lyric activity was in the CD8+ frac-
tion (Fig. 6 A), as reported previously with live virus (20) .
When the T cells were purified before stimulation with vi-
rus-pulsed dendritic cells, the bulk of the cytolytic response
was induced from the CD8+ subset, but killer activity
could now also be detected in the purified CD4+ subset
Figure 3.
￿
Cytofluorography of dendritic cells exposed to
heat-inactivated virus. Enriched populations of dendritic
cells were uninfected or pulsed with live or heat-inactivated
virus and cultured for 16 h. Cells were fixed, permeabilized
with saponin (25), and stained with anti-NS1 mAb or iso-
type control mAb (anti-CD8), followed by FITC-conju-
gated goat anti-mouse IgG. Dot plots were gated to remove
debris and are of forward scatter versus anti-CD8 (left) or
anti-NS1 (remaining panels). Dendritic cells are the large cell
population and comprise -65% ofthe preparation. Forward Scatter
Inactivated Virus Induces Human CD8+ Cytolytic T Cell ResponsesFigure 4 .
￿
Expression of NSl and NP protein in dendritic cells . Dendritic cells were uninfected (A), pulsed with live (B) or heat-inactivated virus (C)
as in Fig. 3 above, cytospun onto glass slides, and stained with niAbs to NS1 (top) orNP (bottom), as previously described (20) . The arrows point to cells
expressing high levels of NS l and NP.
1667
￿
Bender et al .Figure 5 .
￿
Adsorption ofvirus with CRBC removes CTL-inducing ac-
tivity and target cell sensitization . Partially enriched preparations of den-
dritic cells were pulsed with live or heat-inactivated virus before or after
adsorption to CRBC and then tested for their ability to stimulate CTL
responses (top) . Percent CTL activity is shown on infected macrophage
targets . E/T ratio was 50:1 . CRBC adsorbed or unabsorbed preparations
of allantoic fluid-derived virus were also tested at the target level for sen-
sitization ofmacrophages (bottom) . CRBC (-) refers to fractions ofvirus
after adsorption to CRBC . Percent CTL activity is shown on infected
macrophage targets. E/T ratio was 40 :1 . Lysis of uninfected targets was
<5% in all experiments (data not shown) .
(Fig . 6 B) . Thus, as for live virus, CD8+ T cells acquire the
capacity to become CTLs when few or no CD4+ T cells
are present . In all respects, therefore, noninfectious forms
of influenza virus are as efficient as live virus in inducing
human CTL responses, provided they are presented by
dendritic cells .
Loss of Fusogenic Activity Decreases Virus Presentation .
￿
To
determine whether live and heat-inactivated influenza virus
must access the cytoplasm to be presented, we pretreated
both forms of virus at pH 5 . This destroys fusogenic capac-
ity, and therefore delivery of nucleocapsid to the cyto-
plasm, but not hemagglutinating activity (24) . Treatment at
pH 5 rendered the virus less able to sensitize dendritic cells
for inducing CTL responses from purified CD8+ T cells
(Fig . 7) .We substantiated thatlowpH treatment of live vi-
rus reduced infectivity by >4 X 104-fold in standard viral
plaque assays (data not shown) . Thus it is likely that access
to the cytoplasm was significantly diminished with this
treatment . Another approach to block viral fusion, e.g.,
NH4C1 or chloroquine treatment ofAPCs, which neutral-
izes endosomal pH, also interferes with antigen processing
and therefore is not as selective.
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(A) Influenza virus-specific CTLs generated to heat-inacti-
vated virus are CD8 + . After7 dofculture, T cells stimulated with unin-
fected or heat-inactivated influenza-infected APCs were stained with
CD4-FITC and CD8-PE mAbs and sorted on a FACStar® Plus (Becton
Dickinson and Co .) . The CD4+ and CD8+ populations were >98%
pure . Bulk refers to unsorted T cells . Lyric activity ofeach population was
measured on infected syngeneic macrophage targets . Results are represen-
tative ofthree experiments . (B) Heat-inactivated influenza virus stimulates
the development of both CD4+ and CD8+ CTLs . Bulk and purified T
cell subsets (CD4+ or CD8+) were stimulated with live or heat-inacti-
vated virus-pulsed APCs for 7 d . Cytolytic activity was measured as in
(A) . Results are representative of four experiments . Lysis of uninfected
targets inA or B was <5% (data not shown) .
Discussion
Inactivated Influenza Virus Elicits Potent Human CTL Re-
sponses . Our data show that nonreplicating influenza virus
is comparably effective to live virus in generating CD8+
CTL responses, as long as the virus is delivered to dendritic
cells . Prior work has shown that UV-inactivated influenza
virus does not charge various target cells for effector cell
recognition (8, 13-15) . In these studies, CTL-mediated ly-
sis of influenza virus-infected target cells presumably re-
quired new viral protein synthesis . Heat inactivated influ-
enza virus sensitized L929 target cells forCTL recognition
by murine T cells (14, 30) . In our hands, however, human
monocytes were poor targets for CTLs with this form of
virus at standard doses of 1,000 HAU/ml (unpublished
data) . The important differences in our studies are the use
of specialized APCs, dendritic cells . These APCs can in-
duce CTLs from resting precursors and probably require
very low levels ofprocessed antigen to do so .
The mechanism by which the influenza virus is rendered
Inactivated Virus Induces Human CD8+ CytolyticT Cell ResponsesU
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Figure 7.
￿
Induction of influenza virus-specific CD8+ CTLs is depen-
dent upon its fusogenic activity. Live or heat-inactivated influenza virus
(sucrose density gradient purified) was incubated in citrate buffer at pH 5
or pH 7 for 30 min at 37°C (see Materials and Methods). APCs were
pulsed with 1,000 HAU/rnl of the different virus preparations and added
to purified syngeneic CD8+ T cells. Cytolytic activity was measured after
6-7 d. Each different symbol represents a separate experiment. E/T ratio =
50-40:1 . Lysis ofuninfected targets was <5% (data not shown).
nonreplicating has been ascribed to cross-linking of viral
nucleic acid in the case ofUV treatment, and possibly inac-
tivation of viral polymerases (28, 31) in the case of heat
treatment. Short courses of heat treatment (1-3 min) de-
stroy the neuraminidase activity (13), which is thought to
be required for normal viral replication and release from in-
fected cells (32) . From the data presented here, we presume
that the inactivated influenza virus gains access to the now
classical, cytoplasmic machinery for processing and presen-
tation on MHC class I molecules. pH 5 treatment of heat-
inactivated virus substantially reduced the ability to induce
CTL responses from purified CD8+ T cells (Fig. 7). In
contrast, the ability to generate CTL responses from CD4+
T cells was unaffected (data not shown). The alternative,
that a specialized endocytic compartment for processing
antigens onto class I is used (the so-called exogenous path-
way that has been profferred in several studies [33-35]), re-
mains a possibility since pH 5 inactivation of virus did not
completely ablate CTL induction (Fig. 7).
Dendritic Cells Are Specialized APCs for Inducing Human
CTL Responses. The efficacy of dendritic cells as APCs
for CD8+ killer cell responses may be explained by three
critical functional properties. The first is that only small
amounts of MHC-associated ligand need to be presented
on the surface of the dendritic cell. This became evident
initially in studies of MHC class 11 presentation of superan-
tigens (36) . Only a few hundred MHC-superantigen com-
plexes suffice to elicit a CD4+ T cell proliferative response
from naive human T cells. In the current study with CD8+
T cells, MOIs of 2-4 to 0.02-0.04 (1,000-10 HAU/ml) for
live virus are sufficient to induce strong CTL responses
(Fig. 2). For heat-inactivated virus where infectivity is re-
duced >106 fold (Table 1), the MOI with "infectious vi-
rus" is considerably lower, <2-4 X 10-6-10-8. At these
doses, infectious live virus is ineffective in inducing CTL
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responses. Thus dendritic cells do not require actively rep-
licating virus to charge their class I molecules. The proteins
brought in by incoming heat-inactivated virions are suffi-
cient to elicit CTLs. This is supported by data obtained
with cytochemistry and cytofluorography (Figs. 3 and 4)
showing little or no expression of NP or NS1 in dendritic
cells pulsed with heat inactivated virus. Whether dendritic
cells use exogenous pathways for processing MHC class I
molecules, as demonstrated for macrophages (35), remains
to be determined. Preliminary studies with influenza virus
expressing uncleaved HA, which lacks fusogenic capacity,
indicate that access to the cytoplasm is necessary for optimal
induction of CTL responses.
The second important feature of dendritic cells that has
bearing on the generation of CD8+ T cells is their expres-
sion of known accessory or costimulatory molecules for T
cell stimulation. These include CD80, CD86, LFA1 and 3,
intracellular adhesion molecule-1 and 3, and CD40 (37-40).
The third feature is that dendritic cells are distributed in
situ in such a way that they can pick up foreign antigens and
then migrate to appropriate sites to interact with both
memory and naive T cells. For example, dendritic cells are
found in airway epithelium, the entry point for influenza
virus in mammals. After exposure to antigens, dendritic
cells can migrate from the airway to the T cell areas of the
draining lymph nodes where T cells are then sensitized to
the corresponding antigens (41, 42) .
Inactivated Virus As An Immunogen for CTL Responses.
Subunit and split influenza virus preparations that are cur-
rently used in vaccine formulations preferentially induce
humoral rather than cytolytic responses in man. The viral
antigens, e.g., HA, to which antibody responses are boosted
undergo frequent antigenic shift and drift, and consequently
yearly vaccination with new circulating virus preparations
is needed. The appearance of influenza virus-specific CTLs
is associated with a more rapid clearance ofvirus from nasal
washings (2) . The advantage of CTLs is that they are di-
rected towards conserved internal viral proteins, e.g., NP,
and therefore are cross-reactive for several virus subtypes (2).
Our findings are important for the development of vac-
cines and therapies that will elicit the generation of CD8+
CTLs from quiescent human T cells. In animal models, live
viral vectors engineered to express foreign antigens have
been used to induce immunity against many pathogens
(43-47) . Influenza virus that is both heat-treated and UV-
irradiated primes mice for secondary CTL responses in vitro
(30). Nonreplicative recombinant Semliki Forest virus ex-
pressing the NP influenza gene induces specific CD8+ CTL
responses in mice (48). However, the potential usefulness
of these vectors as vaccine delivery systems remains to be
established in humans.
The use ofnonreplicating influenza virus, together with
dendritic cells, offers certain advantages over subunit and
split virus preparations. First, influenza virus would be ex-
pected to have little pathogenicity in the blood stream, and
therefore could be delivered in inactivated form on den-
dritic cells to prime or expand CTL function in vivo. Sec-
ond, influenza virus can be engineered to express foreignantigenic epitopes into HA and neuraminidase (49) . These
have been demonstrated to contribute to the development
of CD8+ T cell-protective responsesin mice against malaria
(46, 47). By virtue of its capacity to target dendritic cells,
influenza virus, even nonreplicating virus, may be superior
to strategies that do not target these specialized APO.
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